Home › FDA Implements New Tools for Development, Evaluation of Zika Virus Detection Tests

FDA Implements New Tools for Development, Evaluation of Zika Virus Detection Tests

Aug 18, 2017

NEW YORK (GenomeWeb) – The US Food and Drug Administration (FDA) announced today that it is offering a panel of human plasma samples to assist in the regulatory evaluation of serological tests to detect recent Zika virus infection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Point-of-Care Molecular Diagnostic Platform That Skips Need for Amplification Being Developed at UCLA

    Premium

  2. Mayo Clinic Spinout Phenomix Sciences Launches $1M Seed Funding Round

  3. BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

  4. FDA, Industry Willing to Collaborate on Dx Regulation via Legislation Despite Differences

    Premium

  5. NantHealth Q3 Revenues Grow 2 Percent as Reimbursement Issues Frustrate

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.